(Q36328196)
Statements
CCT244747 is a novel potent and selective CHK1 inhibitor with oral efficacy alone and in combination with genotoxic anticancer drugs (English)
Mike I Walton
Paul D Eve
Angela Hayes
Melanie R Valenti
Alexis K De Haven Brandon
Gary Box
Albert Hallsworth
Elizabeth L Smith
Kathy J Boxall
Michael Lainchbury
Thomas P Matthews
G Wynne Aherne
John C Reader
Suzanne A Eccles
Ian Collins
Michelle D Garrett
28 August 2012